Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Bartalucci

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Ebiomedicine|July 25, 2020
The utility of a methylation panel in the assessment of clinical response to radiofrequency ablation for Barrett's esophagusWladyslaw Januszewicz, Vinod V Subhash, William Waldock, et al.
Therapeutic Advances in Gastroenterology|July 30, 2025
Real-world outcomes from the UK IBD Registry on second-line biologic therapy following anti-TNF exposure in Crohn's disease: results from the BISCUITS studyFrederick Taylor, Giorgio Bartalucci, Catherine Gleave, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Ebiomedicine|July 25, 2020
The utility of a methylation panel in the assessment of clinical response to radiofrequency ablation for Barrett's esophagusWladyslaw Januszewicz, Vinod V Subhash, William Waldock, et al.
Therapeutic Advances in Gastroenterology|July 30, 2025
Real-world outcomes from the UK IBD Registry on second-line biologic therapy following anti-TNF exposure in Crohn's disease: results from the BISCUITS studyFrederick Taylor, Giorgio Bartalucci, Catherine Gleave, et al.
Pageof 1